close
close

SARS-CoV-2: Risk for expansion of nirmatrelvir resistance as a minor attack

SARS-CoV-2: Risk for expansion of nirmatrelvir resistance as a minor attack

Boston/Cambridge –Stämme von SARS-CoV-2 may be resistant to Nirmatrelvir entwickeln. American Wissenschaftler has the Häufigkeit …